NOVAREX Co.,Ltd. (KOSDAQ:194700)
South Korea · Delayed Price · Currency is KRW 8,560.00
-180.00 (-2.06%)
At close: Nov 13, 2026
NOVAREX Market Cap
NOVAREX has a market cap or net worth of 147.25 billion as of November 13, 2026. It is the 24,187th most valuable company in the world and the 971st biggest in South Korea. Its market cap has decreased by 49.74% in one year.
Market Cap
147.25B
Enterprise Value
135.00B
Revenue
404.26B
Global Rank
Country Rank
#971 South Korea
PE Ratio
4.28
ChartMarket Cap Chart
Since November 14, 2018, NOVAREX's market cap has decreased from 180.98B to 147.25B, a decrease of -18.63%. That is a compound annual growth rate of -2.54%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 13, 2026 | 147.25B | -40.58% |
| Dec 30, 2025 | 247.83B | 86.67% |
| Dec 30, 2024 | 132.77B | -38.22% |
| Dec 28, 2023 | 214.90B | 19.61% |
| Dec 29, 2022 | 179.68B | -41.23% |
| Dec 30, 2021 | 305.72B | -1.28% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 14, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ImmuneOncia Therapeutics | 230.33B |
| Vivozon Pharmaceutical | 185.31B |
| DAE HWA Pharmaceutical | 174.09B |
| GC WellBeing | 170.58B |
| HEM Pharma | 164.37B |
| CellBion | 160.93B |
| Kyung Dong Pharmaceutical | 144.01B |
| PHARMARESEARCH BIO | 117.06B |